Full-Time

Manufacturing Quality Assurance Lead

Folsom

Posted on 7/13/2026

Agilent Technologies

Agilent Technologies

10,001+ employees

Provides eProcurement automation and hosted catalogs

Compensation Overview

$132.9k - $207.6k/yr

+ Bonus + Stock

Company Does Not Provide H1B Sponsorship

Folsom, CA, USA

In Person

On-site role; day shift; requires in-person presence at Folsom, California.

Bachelor's, Master's

Category
QA & Testing (1)
Required Skills
ISO 9001
Risk Management

Get referred to Agilent Technologies

See people who can refer or advise you

Requirements
  • Bachelor's or Master's Degree, or equivalent, in Chemistry, Life Sciences, Engineering, or related field.
  • Minimum 8 years’ experience with Quality Assurance, ISO Compliance, and/or Quality Management Systems.
  • Experience with ISO 9001:2015, or similar.
  • Experience preparing for and hosting audits.
  • Experience with multiple QMS processes: Change Control, Training Management, Nonconformance Management, Corrective and Preventative Actions, Design Control, Risk Management, and/or Validation.
  • Effective communication skills with ability to work independently and collaborate with cross-functional and global teams.
Responsibilities
  • Own the local ISO 9001:2015 QMS processes in alignment with Agilent-, group-, and division-level QMS including Nonconformance Management, Corrective and Preventative Actions (CAPA), Change Control, Training, Risk Management, and Process and Equipment Validation.
  • Ensure an effective Training Management process at the site with clarity for roles and responsibilities, employee qualifications, and training requirements.
  • Provide Quality Assurance support to Manufacturing for production issues to ensure alignment and conformity to the appropriate QMS processes.
  • Collaborate with Manufacturing and Supply Chain for product shipment holds and support Product Investigations and Field Actions.
  • Continuously monitor product quality and process controls through face-to-face engagement with Manufacturing personnel to identify opportunities and support continuous improvement.
  • Oversee incoming, in-process, and Quality Control (QC) inspection and approve inspection plans.
  • Monitor and report Quality and Customer Experience data against established metrics. Ensure ownership and accountability of actions to address off-target or negatively trending performance.
  • Lead audit management activities for the site including scope definition, audit preparation, host audits, support actions to address findings, and communicate to stakeholders.
  • Represent Quality Assurance during customer interactions for QMS Questionnaires, Quality Agreements, Change Notifications.
  • Support Design Transfer activities for new and revised products managed under the Product Lifecycle (PLC) process.
  • Collaborate with Supplier Quality to ensure supplier management processes are effective and aligned with the site needs.

Agilent Technologies provides eProcurement services that help businesses buy supplies more efficiently. It offers a suite of electronic procurement tools that let clients load their pricing into existing purchasing platforms, access a hosted catalog, and complete transactions digitally without paper. The service connects pricing data to clients’ procurement systems, delivers an online catalog, and supports automated, paperless purchasing workflows. This makes purchasing faster and reduces manual steps. Compared with competitors, Agilent emphasizes automation, quick connectivity between pricing, catalogs, and purchasing platforms, and a reliable, scalable experience backed by its broad product range. The company aims to improve client productivity and lower procurement costs, helping customers buy what they need more easily while keeping prices clear and consistent.

Company Size

10,001+

Company Stage

IPO

Headquarters

Santa Clara, California

Founded

1999

Get referred to Agilent Technologies

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Agilent raised fiscal 2026 revenue to $7.39-$7.49 billion and EPS to $6.00-$6.10.
  • Q2 2026 core revenue grew 6.3% while non-GAAP operating margin reached 26.4%.
  • FDA expanded PD-L1 22C3 use on Dako Omnis across four additional cancers.

What critics are saying

  • Agilent’s 2024-2026 layoffs signal slower equipment demand and ongoing margin pressure.
  • China revenue remains exposed; management expects stimulus orders to slip into fiscal 2027.
  • Patent fights and settlements with Axion and Synthego show expensive IP vulnerability ahead.

What makes Agilent Technologies unique

  • Agilent owns sticky workflows: OpenLab Sync, Dako Omnis, and CrossLab integrate regulated labs.
  • Biocare acquisition adds clinical pathology antibodies, expanding recurring diagnostics revenue beyond instruments.
  • Altura columns and xCELLigence AI deepen consumables lock-in across biopharma analysis workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Performance Bonus

Stock Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Associated Press
Jul 20th, 2026
Agilent leads funding round in HALO X-ray Technologies for airport security tech

HALO X-ray Technologies, a UK-based X-ray detection technology company, has completed a funding round led by Agilent Technologies, with participation from existing investors UKI2S and MEIF. The company has developed advanced X-ray diffraction technology designed to help security operators make faster screening decisions at airports and borders. Unlike conventional X-ray systems, HALO's technology provides more precise material identification, helping distinguish genuine threats from everyday items. The investment will support HALO's move towards commercialisation and global market expansion. Geoff Winkett, vice president at Agilent Spectroscopy & Vacuum Division, said the investment reflects confidence in the transformative potential of HALO's technology. CEO Simon Godber described the funding as "genuinely transformational", providing the runway needed to realise the potential of the company's technology and scale commercially.

Associated Press
Jul 8th, 2026
Agilent launches Altura SEC and PLRP-S columns for biotherapeutic analysis workflows

Agilent Technologies has expanded its Altura HPLC column portfolio with new size exclusion chromatography and PLRP-S columns for biopharmaceutical analysis. The columns support analytical workflows for peptides, proteins, oligonucleotides, and conjugated therapeutics. The new products incorporate Agilent's Ultra Inert technology to improve peak shape and aggregate recovery. For GLP-1 peptide analysis, Altura SEC columns deliver up to double the sensitivity of competitor inert columns. The PLRP-S columns are designed for liquid chromatography/mass spectrometry workflows under demanding conditions. David Edwards, vice president at Agilent's Chemistries and Supplies Division, said customer reception of initial Altura columns has been overwhelmingly positive. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide.

Minichart
Jun 26th, 2026
Agilent closes $600M senior notes offering with 4.900% rate due 2032

Agilent Technologies has closed a $600 million offering of 4.900% senior notes due 2032, the company announced on 25 June 2026. The notes were sold privately to qualified institutional buyers under Rule 144A and non-US persons under Regulation S. The notes carry a fixed 4.900% annual coupon with principal due on 15 January 2032. Interest payments will be made semi-annually starting 15 January 2027. Agilent entered into a registration rights agreement requiring it to file an exchange offer registration statement. If registration obligations are not met by 25 June 2027, the interest rate will increase by 0.25% for the first 90 days of default, up to a maximum additional 0.50% annually. The notes include a change of control provision allowing holders to require repurchase at 101% of principal plus accrued interest.

Yahoo Finance
Jun 21st, 2026
Agilent Technologies raises guidance, adds AI diagnostics with Biocare acquisition

Agilent Technologies has raised its full-year revenue and earnings per share guidance after reporting stronger-than-expected first and second quarter results. The laboratory equipment maker is also acquiring Biocare to expand its cancer diagnostics capabilities and plans to open a China Innovation Centre focused on digital technology, artificial intelligence and automation. The company is leveraging its IGNITE operating system to drive efficiency gains and margin improvements whilst expanding recurring revenue from consumables and services. Analysts project the moves could support Agilent's push into AI-driven automation and diagnostics, though tariff-related costs and supply chain complexity remain key risks. Simply Wall St community members currently value Agilent's shares between $150.54 and $165.53, suggesting potential upside from current levels based on the company's margin expansion efforts.

Yahoo Finance
Jun 16th, 2026
Madison Large Cap Fund holds Agilent amid AI disruption fears in life sciences tools sector

Madison Large Cap Fund maintained its position in Agilent Technologies during the first quarter of 2026, despite the stock being among the fund's top five detractors. The fund declined 2.7%, outperforming the S&P 500's 4.33% fall. Agilent, a life sciences and diagnostics solutions provider, reported results consistent with expectations, though its 2026 recovery outlook disappointed investors. The stock also faced concerns about AI technology potentially reducing demand for laboratory instruments by enabling simulated research experiments. Madison dismissed these AI risks as unlikely, noting early-stage R&D represents only a small portion of Agilent's revenue. The company reported $1.83 billion in second-quarter revenue, up 6.3% on a core basis. As of 15 June 2026, Agilent traded at $130.59 per share with a market capitalisation of $36.88 billion.

INACTIVE